<DOC>
	<DOCNO>NCT00907673</DOCNO>
	<brief_summary>A 28-week , feasibility study investigate safety efficiency Automatic Fluid Shunt patient chronic congestive heart failure , ascites diuretic resistance .</brief_summary>
	<brief_title>The Automated Fluid Shunt ( AFS ) Chronic Congestive Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Ascites</mesh_term>
	<criteria>Female male patient ≥ 18 year age A clinical diagnosis chronic congestive heart failure &gt; 6 month At least one episode document ADHF previous 6 month NYHA functional class IIIIV Circulating level NTproBNP ≥ 800 ng/L . Stable , optimized therapy heart failure least 4 week prior enrollment Echocardiography perform within 3 month Detectable ascites ultrasound and/or compute tomography Diuretic resistance define daily dose furosemide &gt; 80 mg , torsemide &gt; 40 mg bumetanide &gt; 2 mg Written inform consent Present recur systemic local infection , peritonitis , urinary tract infection , abdominal skin infection . Ongoing malignant disease adverse prognosis Evidence firmly loculated peritoneal effusion . Obstructive uropathy Severely reduced renal function ( SCreatinine 300 mol/l ) endstage renal disease require dialysis Severe liver disease ( ASAT and/or ALAT and/or total bilirubin three time upper limit normal range laboratory value ) Pregnancy Requirement intravenous inotropes Acute coronary syndrome condition require emergency treatment Heart disease require surgical intervention course study Any clinically significant disease could adversely affect study participation judge Investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
</DOC>